Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D Bunting

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Blood|February 17, 2005
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisUte Modlich, Olga S Kustikova, Manfred Schmidt, et al.
Blood|June 26, 2008
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cellsPeter A Cohen, Gary K Koski, Brian J Czerniecki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2013
Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathwayJosephine Fernando, Travis W Faber, Nicholas A Pullen, et al.
Nature Immunology|December 4, 2012
The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90Chenhui Wang, Ling Wu, Katarzyna Bulek, et al.
Cell Reports|December 3, 2014
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven LeukemogenesisAnindya Chatterjee, Joydeep Ghosh, Baskar Ramdas, et al.
Blood|July 19, 2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KITRaghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, et al.
Blood|April 26, 2003
Stat5 expression is critical for mast cell development and survivalChristopher P Shelburne, Margaret E McCoy, Roland Piekorz, et al.
Oncotarget|June 17, 2015
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasisJino Park, Michaela Schlederer, Martin Schreiber, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Blood|February 17, 2005
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisUte Modlich, Olga S Kustikova, Manfred Schmidt, et al.
Blood|June 26, 2008
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cellsPeter A Cohen, Gary K Koski, Brian J Czerniecki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2013
Genotype-dependent effects of TGF-β1 on mast cell function: targeting the Stat5 pathwayJosephine Fernando, Travis W Faber, Nicholas A Pullen, et al.
Nature Immunology|December 4, 2012
The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90Chenhui Wang, Ling Wu, Katarzyna Bulek, et al.
Cell Reports|December 3, 2014
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven LeukemogenesisAnindya Chatterjee, Joydeep Ghosh, Baskar Ramdas, et al.
Blood|July 19, 2012
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KITRaghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, et al.
Blood|April 26, 2003
Stat5 expression is critical for mast cell development and survivalChristopher P Shelburne, Margaret E McCoy, Roland Piekorz, et al.
Oncotarget|June 17, 2015
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasisJino Park, Michaela Schlederer, Martin Schreiber, et al.
Pageof 8